human monoclonal antibodies

About

Our exclusive Native™ Antibody Discovery platform, which is based on antigen-specific B lymphocytes flow cytometry technology, can produce human monoclonal antibodies in a short period of time with natively paired heavy- and light-chains with exceptionally high in vivo specificity and affinity. As an additional advantage of this technology, it can retrieve a larger number of antibody candidates from bone marrow cells, lymph node cells or peripheral blood cells of patients with infectious diseases, autoimmune diseases or cancer. With its distinct native characteristics, the isolated native human antibodies from Creative Biolabs is destined to play a powerful role in developing human antibody medicines for diagnostic and therapeutic use.